T. Rowe Price Associates, Inc. 13D and 13G filings for Generation Bio Co.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 935,159 14.000% | 242,542 (+35.02%) | Filing |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 692,617 10.500% | -33,487 (-4.61%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 726,105 12.200% | -138,608 (-16.03%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 864,712 15.100% | 230,351 (+36.31%) | Filing |
| 2021-02-10 12:15 pm Purchase | 2021-01-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 634,361 11.300% | 194,943 (+44.36%) | Filing |
| 2021-02-10 12:15 pm Purchase | 2020-12-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 439,418 9.400% | 439,418 (New Position) | Filing |